Literature DB >> 11737306

A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene.

A E Noffsinger1, J M Belli, M A Miller, C M Fenoglio-Preiser.   

Abstract

AIMS: The p53 protein is implicated in the control of cell proliferation, differentiation, and death. As part of a study characterizing p53 alterations in colonic mucosa of patients with ulcerative colitis, we identified a unique pattern of basal p53 immunoreactivity. METHODS AND
RESULTS: Tissue samples (n=180) from 42 ulcerative colitis patients were evaluated for p53 alterations by immunohistochemistry, loss of heterozygosity analysis, polymerase chain reaction-single-strand conformation polymorphism and direct sequencing. In addition, the expression of the p53- associated proteins p21waf1/cip1 and MDM2 was evaluated immunohistochemically. Three basic patterns of p53 immunoreactivity were observed: (i) isolated immunoreactive cells in the crypt bases; (ii) strongly positive cells confined to the basal half of the glands; and (iii) diffusely staining cells. The basal staining pattern was observed in both non-neoplastic tissues and in some areas of dysplasia, and was associated with normal expression of p21waf1/cip1 in all cases, and with p53 mutation in seven of 11 cases.
CONCLUSIONS: The basal pattern of p53 expression is associated with mutation in the p53 gene, and appears to be an early change in a subgroup of ulcerative colitis patients. The significance of this pattern of immunoreactivity and the mechanism by which it develops are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737306     DOI: 10.1046/j.1365-2559.2001.01274.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  11 in total

Review 1.  Infection, inflammation, and gastrointestinal cancer.

Authors:  C R Boland; M G Luciani; C Gasche; A Goel
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

2.  Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.

Authors:  Tomer Cooks; Ioannis S Pateras; Ohad Tarcic; Hilla Solomon; Aaron J Schetter; Sylvia Wilder; Guillermina Lozano; Eli Pikarsky; Tim Forshew; Nitzan Rosenfeld; Nitzan Rozenfeld; Noam Harpaz; Steven Itzkowitz; Curtis C Harris; Varda Rotter; Vassilis G Gorgoulis; Moshe Oren
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

3.  Expression of p53, VEGF, microvessel density, and cyclin-D1 in noncancerous tissue of inflammatory bowel disease.

Authors:  Canan Alkim; Berna Savas; Arzu Ensari; Huseyin Alkim; Ulku Dagli; Erkan Parlak; Aysel Ulker; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2008-11-26       Impact factor: 3.199

4.  Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.

Authors:  Elli E Ioachim; Konstantinos H Katsanos; Michael C Michael; Epameinondas V Tsianos; Niki J Agnantis
Journal:  Int J Colorectal Dis       Date:  2004-04-02       Impact factor: 2.571

5.  Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.

Authors:  Davy Carlos Mendes Rapozo; Ana Braunstein Grinmann; Ana Teresa Pugas Carvalho; Heitor Siffert P de Souza; Sheila Coelho Soares-Lima; Tatiana de Almeida Simão; Daurita de Paiva; Flávio Abby; Rodolpho Mattos Albano; Luiz Felipe Ribeiro Pinto
Journal:  Int J Colorectal Dis       Date:  2009-06-20       Impact factor: 2.571

Review 6.  Microscopic features of colorectal neoplasia in inflammatory bowel diseases.

Authors:  Aude Bressenot; Virginie Cahn; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

7.  Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.

Authors:  Karoline Horisberger; Thomas Ried; Timo Gaiser; Daniela Hirsch; Darawalee Wangsa; Yuelin J Zhu; Yue Hu; Daniel C Edelman; Paul S Meltzer; Kerstin Heselmeyer-Haddad; Claudia Ott; Peter Kienle; Christian Galata
Journal:  Clin Cancer Res       Date:  2018-07-02       Impact factor: 12.531

8.  Molecular characterization of ulcerative colitis-associated colorectal carcinomas.

Authors:  Daniela Hirsch; Julia Hardt; Christian Sauer; Kerstin Heselmeyer-Hadded; Stephanie H Witt; Peter Kienle; Thomas Ried; Timo Gaiser
Journal:  Mod Pathol       Date:  2020-12-14       Impact factor: 7.842

Review 9.  p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.

Authors:  Kazuhiro Kobayashi; Hiroyuki Tomita; Masahito Shimizu; Takuji Tanaka; Natsuko Suzui; Tatsuhiko Miyazaki; Akira Hara
Journal:  Int J Mol Sci       Date:  2017-06-16       Impact factor: 5.923

10.  Immunohistochemical assessment of a unique basal pattern of p53 expression in ulcerative-colitis-associated neoplasia using computer-assisted cytometry.

Authors:  Shunsuke Kobayashi; Takahiro Fujimori; Hiroyuki Mitomi; Shigeki Tomita; Kazuhito Ichikawa; Johji Imura; Shigehiko Fujii; Michihiro Itabashi; Shingo Kameoka; Yoshinori Igarashi
Journal:  Diagn Pathol       Date:  2014-05-29       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.